TGTX

Tg Therapeutics INC

+$439.1M

Net Activity

Institutions Holding

361

Popularity Rank

#1629

Avg Weight

0.14%

Total Value

$3.6B

Ownership Trend

361 institutions currently hold TGTX, with 194 net buyers and 160 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

160

Net Buying Institutions

194

Key Holders

Key Holders

Top 5 by Value

BI
BlackRock, Inc.
$739.2M
SS
State Street CORP
$287.3M
VP
Vanguard Portfolio Management LLC
$274.9M
VC
Vanguard Capital Management LLC
$219.4M
SC
Soleus Capital Management, L.P.
$133.9M

Top 5 by Conviction

OC
Occam Crest Management LP
11.66%
SC
Soleus Capital Management, L.P.
5.42%
OM
Opaleye Management Inc.
2.34%
PC
Penn Capital Management Company, LLC
1.40%
6C
683 Capital Management, LLC
1.02%
View all 361 holding institutions

Quarterly Activity

Recent Activity

+$2.4B

Total Buy Value

$935.2M

Total Sell Value

New buy60
Trim110
Add134
Sold out50

194

Net Buyers

160

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding TG THERAPEUTICS INC (TGTX)?
Major stakeholders currently include BlackRock, Inc. ($739.2M), State Street CORP ($287.3M), Vanguard Portfolio Management LLC ($274.9M). Based on the latest 13F filings, there are a total of 361 tracked investment funds and institutions maintaining positions in TGTX.
What is the overall institutional sentiment toward TGTX recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $439.1M, driven by 194 managers accumulating shares while 160 reduced their exposure.
Which institutions have been selling or reducing their TGTX positions?
In the latest period, 110 funds trimmed their holdings, and 50 managers completely exited their positions. The aggregate reported sell value was $935.2M.
Are there any notable investors adding TGTX to their portfolios?
Yes, buying activity remains notable. 60 institutions opened new positions in {ticker}, and 134 existing holders added to their shares. The total reported buy value for the quarter amounted to $2.4B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,603

Total reported value

$438.8B

323 institutions currently hold both TGTX and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,337

Total reported value

$730.5B

328 institutions currently hold both TGTX and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

4,024

Total reported value

$283.9B

320 institutions currently hold both TGTX and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail